Sponsor Deadline
Posted: 4/18/2022

Telehealth in Postmenopausal Patient Care

Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies. Pfizer’s GMG competitive grant program involves a publicly posted general Request for Proposal (RFP) that provides detail regarding a general area of interest, sets timelines for review and approval, and uses an internal Pfizer review process to make final grant decisions. Organizations are invited to submit an application addressing the knowledge gaps as outlined in the specific RFP.

During the COVID-19 pandemic, the need for telehealth to deliver patient care has increased. Through this RFP, it is our intent to support programs focused on the education of healthcare practitioners (HCPs) to better leverage technology and utilize telehealth to optimize the hormone therapy benefit/risk discussion with postmenopausal patients.

Grant Application due date: September 3, 2020

Eligibility Requirements

Geographic Scope: United States

• The following may apply: medical, nursing, allied health, professional schools; healthcare institutions (both large and small); professional associations and medical societies; medical education companies; and other entities with a mission related to healthcare professional education and/or healthcare improvement. • If the project involves multiple departments within an institution and/or between different institutions / organizations / associations. All institutions must have a relevant role and the requesting organization must have a key role in the project. • For projects offering continuing education credit, the requesting organization must be accredited.

Amount Description

• Individual projects requesting up to $100,000 will be considered. The estimated total available budget related to this RFP is $300,000

Funding Type